Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yi Ban

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Science Advances|November 7, 2025
Oligo-CALL: A next-generation barcoding platform for studying resistance to targeted therapyYingzhuo Liu, Yi Ban, Dingcheng Gao
Advances in Experimental Medicine and Biology|October 14, 2016
Regulation of Interleukin-12 Production in Antigen-Presenting CellsHua Zheng, Yi Ban, Fang Wei, et al.
The Journal of Biological Chemistry|August 12, 2009
Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forksChao-Po Lin, Yi Ban, Yi Lisa Lyu, et al.
Frontiers in Biology|February 19, 2019
Metastatic tumor cells - genotypes and phenotypesDingcheng Gao, Vivek Mittal, Yi Ban, et al.
Journal of Asian Natural Products Research|August 19, 2007
Effect of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside on lipoprotein oxidation and proliferation of coronary arterial smooth cellsQi-Li Liu, Jun-Hua Xiao, Rong Ma, et al.
Molecular and Cellular Biology|August 14, 2013
Activation of a novel ubiquitin-independent proteasome pathway when RNA polymerase II encounters a protein roadblockYi Ban, Chia-Wen Ho, Ren-Kuo Lin, et al.
The Journal of Biological Chemistry|June 3, 2008
A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexesChao-Po Lin, Yi Ban, Yi Lisa Lyu, et al.
Carbohydrate Research|April 3, 2017
Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residuesAhmad S Altiti, Xiaojing Ma, Lixing Zhang, et al.
F1000Research|February 27, 2016
Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cellsXiaojing Ma, Wenjun Yan, Hua Zheng, et al.
Cancer Biology & Therapy|October 2, 2018
<i>CMTR1-ALK</i>: an <i>ALK</i> fusion in a patient with no response to ALK inhibitor crizotinibXue Du, Yun Shao, Hongjun Gao, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Science Advances|November 7, 2025
Oligo-CALL: A next-generation barcoding platform for studying resistance to targeted therapyYingzhuo Liu, Yi Ban, Dingcheng Gao
Advances in Experimental Medicine and Biology|October 14, 2016
Regulation of Interleukin-12 Production in Antigen-Presenting CellsHua Zheng, Yi Ban, Fang Wei, et al.
The Journal of Biological Chemistry|August 12, 2009
Proteasome-dependent processing of topoisomerase I-DNA adducts into DNA double strand breaks at arrested replication forksChao-Po Lin, Yi Ban, Yi Lisa Lyu, et al.
Frontiers in Biology|February 19, 2019
Metastatic tumor cells - genotypes and phenotypesDingcheng Gao, Vivek Mittal, Yi Ban, et al.
Journal of Asian Natural Products Research|August 19, 2007
Effect of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside on lipoprotein oxidation and proliferation of coronary arterial smooth cellsQi-Li Liu, Jun-Hua Xiao, Rong Ma, et al.
Molecular and Cellular Biology|August 14, 2013
Activation of a novel ubiquitin-independent proteasome pathway when RNA polymerase II encounters a protein roadblockYi Ban, Chia-Wen Ho, Ren-Kuo Lin, et al.
The Journal of Biological Chemistry|June 3, 2008
A ubiquitin-proteasome pathway for the repair of topoisomerase I-DNA covalent complexesChao-Po Lin, Yi Ban, Yi Lisa Lyu, et al.
Carbohydrate Research|April 3, 2017
Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residuesAhmad S Altiti, Xiaojing Ma, Lixing Zhang, et al.
F1000Research|February 27, 2016
Regulation of IL-10 and IL-12 production and function in macrophages and dendritic cellsXiaojing Ma, Wenjun Yan, Hua Zheng, et al.
Cancer Biology & Therapy|October 2, 2018
<i>CMTR1-ALK</i>: an <i>ALK</i> fusion in a patient with no response to ALK inhibitor crizotinibXue Du, Yun Shao, Hongjun Gao, et al.
Pageof 4